Located in Scotland, United Kingdom, Omega Diagnostics Group PLC is an
AIM-listed public company on the London Stock Exchange. (Ticker Symbol:
ODX). It was formed in September 2006 when Omega Diagnostics Limited
completed a "reverse acquisition" of an AIM Listed Cash Shell Company
called Quintessentially English PLC. It was established to create products
and systems through acquisitions, new developments and strategic
investments, so enhancing shareholder value.

The Group provides high quality IVD products for use in Hospitals,
Blood Banks, Clinics and Laboratories in over 100 countries.

Omega Diagnostics Limited is a wholly owned subsidiary of the
Group, specialising in the development, manufacture and
marketing of IVD tests for infectious diseases and a variety
of clinical conditions.

For more information on the company please view the Investor
Relations pages.

Andrew Shepherd
Founder and Chief Executive
contact: andrews@omegadiagnostics.co.uk